Related Experiment Videos

Elevated ascitic fluid fibronectin concentration. A non-specific finding

Journal of Hepatology
|January 1, 1986
PubMed

Insights

Ascitic fluid fibronectin levels are elevated in various conditions, not just cancer. This study found fibronectin concentration is not a specific cancer marker in ascites.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Oncology

Background:

  • Ascitic fluid analysis is crucial for diagnosing abdominal conditions.
  • Fibronectin, an extracellular matrix protein, plays roles in cell adhesion and inflammation.
  • Elevated fibronectin has been investigated as a potential biomarker for various diseases.

Purpose of the Study:

  • To investigate the diagnostic utility of ascitic fluid fibronectin concentration.
  • To determine if fibronectin concentration can differentiate between various causes of ascites, including cancer.

Main Methods:

  • Laser nephelometry was used to measure fibronectin concentration in 111 ascitic fluid specimens.
  • Ascitic fluid samples were categorized based on their etiology (e.g., portal hypertension, peritoneal carcinomatosis).
  • Fibronectin concentrations were statistically compared across different etiological groups.

Main Results:

  • Fibronectin concentration was significantly lower in sterile, portal hypertension-related ascites compared to infected ascites, peritoneal carcinomatosis, and other types.
  • Peritoneal carcinomatosis showed the highest fibronectin concentration (123 ± 45 µg/ml).
  • Ascitic fluid fibronectin concentration showed a strong linear correlation with total protein levels (r = 0.81).

Conclusions:

  • Ascitic fluid fibronectin concentration is elevated in multiple conditions beyond cancer.
  • Fibronectin is not a specific diagnostic marker for peritoneal carcinomatosis or cancer in ascites.
  • Further research may explore fibronectin's role in specific inflammatory or infectious processes within ascites.

Related Concept Videos